Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

RCS-01 is safe and may help rejuvenate aging skin.

The Core Curriculum for Hair Restoration Surgery aims to improve doctor training for better, safer, and more natural-looking hair loss treatments.

The cell culture medium "RPMI" might slightly improve hair graft survival, but not by a significant amount.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The International Society of Hair Restoration Surgery created a standard curriculum in 2008 to guide doctors in diagnosing and treating hair loss effectively.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

CAM offers natural hair care solutions that may improve hair health and growth with fewer side effects.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

The CAM is a useful model for studying burn wounds and testing treatments.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Rapp-Hodgkin syndrome, AEC, and EEC are different expressions of the same genetic disorder caused by TP63 gene mutations.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The search scheme SMRI is faster and more secure for retrieving encrypted data from the cloud.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Using both bone marrow concentrate and platelet-rich plasma together improves skin wound healing in mice.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.